Concepedia

Alexandre Loucif

AL

11

Publications

769

Citations

10

H-Index

2006

Active since

Affiliations

Pfizer (United Kingdom)(Current)

Pfizer (United States)

Institut de Pharmacologie Moléculaire et Cellulaire

Discovery Institute

Inserm

Alexandre Loucif is an author at Pfizer (United Kingdom) specializing in medicine, neuroscience, and physiology.

Top concepts

Publications per year

2006–2021

11

Publications

11

Molecular and functional variation in iPSC-derived sensory neurons

Jeremy Schwartzentruber, Stefanie Foskolou, Helena Kilpinen et al. · Nature Genetics · 2017 · 233 citations · Full text

, , +8

Pharmacological reversal of a pain phenotype in iPSC-derived sensory neurons and patients with inherited erythromelalgia

Lishuang Cao, Aoibhinn McDonnell, Anja Nitzsche et al. · Science Translational Medicine · 2016 · 195 citations

A novel selective and orally bioavailable <scp>N</scp> a <scp> <sub>v</sub> </scp> 1.8 channel blocker, <scp>PF</scp> ‐01247324, attenuates nociception and sensory neuron excitability

C. Elizabeth Payne, Adam R. Brown, Jonathon W Theile et al. · British Journal of Pharmacology · 2015 · 96 citations · Full text

A two-hit story: Seizures and genetic mutation interaction sets phenotype severity in SCN1A epilepsies

Ana Rita Salgueiro-Pereira, Fabrice Duprat, Paula A. Pousinha et al. · Neurobiology of Disease · 2019 · 63 citations · Full text

, , +9

GI‐530159, a novel, selective, mechanosensitive two‐pore‐domain potassium (K<sub>2P</sub>) channel opener, reduces rat dorsal root ganglion neuron excitability

Alexandre Loucif, Pierre‐Philippe Saintot, Jia Liu et al. · British Journal of Pharmacology · 2017 · 52 citations · Full text

Rows per page

1–5 of 11